FDA approves supplement 6 for Pharming's Joenja tablets
The efficacy supplement for leniolisib phosphate, reviewed under priority status, was approved with an application letter and label dated September 15, 2026.
Drugs@FDA
Latest
1 story
Sign inSign in1 story
The efficacy supplement for leniolisib phosphate, reviewed under priority status, was approved with an application letter and label dated September 15, 2026.
Drugs@FDA